Sensory thresholds and the antinociceptive effects of GABA receptor agonists in mice lacking the β3 subunit of the GABA(A) receptor

Neuroscience

Volumn 95, Issue 3, 1999, Pages 795-806

  Ugarte, S D ^a   Homanics, G E ^b   Firestone, L L ^b   Hammond, D L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

3 subunit; Allodynia; Antinociception; GABA(A) receptor; GABA(B) receptor; Thermal hyperalgesia

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; BETA CHAIN; BINDING AFFINITY; FEMALE; GENE EXPRESSION; GENE TARGETING; HYPERALGESIA; MALE; MOUSE; NONHUMAN; PERCEPTIVE THRESHOLD; POSTSYNAPTIC MEMBRANE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; SPINAL CORD; STEM CELL; TACTILE STIMULATION;

ANIMALS; BACLOFEN; GABA AGONISTS; HEAT; INJECTIONS, SPINAL; INJECTIONS, SUBCUTANEOUS; ISONICOTINIC ACIDS; ISOXAZOLES; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; NOCICEPTORS; PHYSICAL STIMULATION; PROTEIN ISOFORMS; RECEPTORS, GABA-A; SENSORY THRESHOLDS; SEX CHARACTERISTICS;

EID: 0032761210     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00481-9     Document Type: Article

References (83)

1. Alvarez F.J., Kavookjian A.M., Light A.R. Ultrastructural morphology, synaptic relationships, and CGRP immunoreactivity of physiologically identified C-fiber terminals in the monkey spinal cord. J. comp. Neurol. 329:1993;472-490.
2. Alvarez F.J., Kavookjian Z.M., Light A.R. Synaptic interactions between GABA-immunoreactive profiles and the terminals of functionally defined myelinated nociceptors in the monkey and cat spinal cord. J. Neurosci. 12:1992;2901-2917.
3. A receptor in the mammalian spinal cord. J. comp. Neurol. 365:1996;392-412.
4. A receptors: classification on the basis of subunit structure and receptor function. Pharmac. Rev. 50:1998;291-313.
5. Belhage B., Hansen G.H., Elster L., Schousboe A. Effects of γ-aminobutyric acid (GABA) on synaptogenesis and synaptic function. Perspect. dev. Neurobiol. 5:1998;235-246.
6. Belknap J.K., Lamé M., Danielson P.W. Inbred strain differences in morphine-induced analgesia with the hot plate assay: a reassessment. Behav. Genet. 20:1990;333-338.
7. Belknap J.K., Noordewier B., Lamé M. Genetic dissociation of multiple morphine effects among C57BL/6J, DBA/2J and C3H/HeJ inbred mouse strains. Physiol. Behav. 46:1989;69-74.
8. Berge O., Garcia-Cabrera I., Hole K. Response latencies in the tail-flick test depend on tail skin temperature. Neurosci. Lett. 86:1988;284-288.
9. Bowery N.G. Baclofen: 10 years on. Trends pharmac. Sci. 3:1982;400-403.
10. Bowery N.G. GABAB receptor pharmacology. A. Rev. Pharmac. Toxicol. 33:1993;109-147.
11. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Meth. 53:1994;55-63.
12. A-mediated inhibition following single hair afferent input to single spinal dorsal horn neurones in cats. J. Physiol. 476:1994;89-100.
13. A receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. J. Neurosci. 18:1998;8505-8514.
14. B receptors on Aδ and C primary afferents. Br. J. Pharmac. 81:1984;327-333.
15. Dirig D., Salami A., Rathbun M.L., Ozaki G.T., Yaksh T.L. Characterization of variables defining hindpaw withdrawal latency evoked by radiant thermal stimuli. J. Neurosci. Meth. 76:1997;183-191.
16. Dixon W.J. Efficient analysis of experimental observations. A. Rev. Pharmac. Toxicol. 20:1980;441-462.
17. Drower E.J., Hammond D.L. GABAergic modulation of nociceptive threshold: effects of THIP and bicuculline microinjected in the ventral medulla of the rat. Brain Res. 450:1988;316-324.
18. Elmer G.I., Pieper J.O., Negus S.S., Woods J.H. Genetic variation in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests. Pain. 75:1998;129-140.
19. Finney D. J., (1964) Statistical Method in Biological Assay, p. 668., Hafner Publishing Co., New York.
20. Gerlai R. Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? Trends Neurosci. 19:1996;177-181.
21. Gmelin G., Zimmermann M. Effects of γ-aminobutyrate and bicuculline on primary afferent depolarization of cutaneous fibres in the cat spinal cord. Neuroscience. 10:1983;869-874.
22. Hammond D.L. Intrathecal administration: methodological considerations. Prog. Brain Res. 77:1988;313-320.
23. Hammond D. L. (1989) Inference of pain and its modulation from simple behaviors. In Issues in Pain Measurement (eds Chapman C. R. and Loeser J. D.), pp. 69-91. Raven, New York.
24. Hammond D. L. (1997) Inhibitory neurotransmitters and nociception: role of GABA and glycine. In The Pharmacology of Pain (eds Dickenson A. and Besson J.-M.), pp. 361-384. Springer, Berlin.
25. Hammond D.L., Nelson V., Thomas D.A. Intrathecal methysergide antagonizes the antinociception, but not the hyperalgesia produced by microinjection of baclofen in the ventromedial medulla of the rat. Neurosci. Lett. 244:1998;93-96.
26. Heinricher M.M., Kaplan H.J. GABA-mediated inhibition in rostral ventromedial medulla: role in nociceptive modulation in the lightly anesthetized rat. Pain. 47:1991;105-113.
27. Hill R.C., Maurer R., Buescher H., Roemer D. Analgesic properties of the GABA-mimetic THIP. Eur. J. Pharmac. 69:1981;221-224.
28. 5]enkephalin, a delta opioid agonist, given intracerebroventricularly in the mouse produces antinociception through mediation of spinal GABA receptors. Pharmac. Biochem. Behav. 49:1994;675-682.
29. Homanics G.E., DeLorey T.M., Firestone L.L., Quinlan J.J., Handforth A., Harrison N.L., Krasowski M.D., Rick C.E.M., Korpi E.R., Makela R., Brilliant M.H., Hagiwara N., Ferguson C., Snyder K., Olsen R.W. Mice devoid of γ-aminobutyrate type A receptor β3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc. natn. Acad. Sci. U.S.A. 94:1997;4143-4148.
30. B receptors and substance P in the mouse spinal cord. J. Pharmac. exp. Ther. 248:1989;1026-1033.
31. Hylden J.L.K., Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmac. 67:1980;313-316.
32. Hynes M.D., Leander J.D., Frederickson R.C.A., Ho P.P.K., Johnson D.W., Archer R.A. Evaluation of THIP in standard tests for analgesic activity: occurrence of antinociception and hyperalgesia. Drug Dev. Res. 4:1984;405-419.
33. B receptors in regulation of transmitter release in cerebellar granule neurons. J. Neurosci. Res. 39:1994;646-655.
34. Kest B., Wilson S.G., Mogil J.S. Sex differences in supraspinal morphine analgesia are dependent on genotype. J. Pharmac. exp. Ther. 289:1999;1370-1375.
35. A receptors in the rat caudal trigeminal spinal nucleus. Neurosci. Lett. 186:1995;169-172.
36. 3 subunit knockout mice. Neurosci. Lett. 240:1998;81-84.
37. Krogsgaard-Larsen P., Schultz B., Mikkelsen H., Aaes-Jørgensen T. and Bøgesø K. P. (1981) THIP, isoguvacine, isoguvacine oxide, and related GABA agonists. In Amino Acid Neurotransmitters (eds DeFeudis F. V. and Mandel P.), pp. 69-76. Raven, New York.
38. Lauder J.M., Liu J., Devaud L., Morrow A.L. GABA as a trophic factor for developing monoamine neurons. Perspect. dev. Neurobiol. 5:1998;247-259.
39. Levy R.A., Proudfit H.K. The analgesic action of baclofen [β-(4-chlorophenyl)-γ-aminobutyric acid]. J. Pharmac. exp. Ther. 202:1977;437-445.
40. Lin Q., Peng Y.B., Willis W.D. Role of GABA receptor subtypes in inhibition of primate spinothalamic tract neurons: difference between spinal and periaqueductal gray inhibition. J. Neurophysiol. 75:1996;109-123.
41. A receptors mediate trophic effects of GABA on embryonic brainstem monoamine neurons in vitro. J. Neurosci. 17:1997;2420-2428.
42. A receptor subunit mRNAs in the rat locus coeruleus. Molec. Brain Res. 24:1994;219-226.
43. A receptor subunit mRNAs in rat spinal cord and dorsal root ganglia. J. comp. Neurol. 338:1993;337-359.
44. B receptors and antagonism by CGP 35348, prevent bicuculline- and picrotoxin-induced antinociception. Neuropharmacology. 31:1992;783-791.
45. A receptors. Brain Res. 620:1993;86-96.
46. A-receptor subtypes really occur in the brain? Trends Neurosci. 19:1996;139-143.
47. Mogil J.S., Kest B., Sadowski B., Belknap J.K. Differential genetic mediation of sensitivity to morphine in genetic models of opiate antinociception: influence of nociceptive assay. J. Pharmac. exp. Ther. 276:1996;532-544.
48. Mogil J.S., Richards S.P., O'Toole L.A., Helms M.L., Mitchell S.R., Belknap J.K. Genetic sensitivity to hot-plate nociception in DBA/2J and C57BL/6J inbred mouse strains: possible sex-specific mediation by delta2-opioid receptors. Pain. 70:1997;267-277.
49. Mogil J.S., Richards S.P., O'Toole L.A., Helms M.L., Mitchell S.R., Kest B., Belknap J.K. Identification of a sex-specific quantitative trait locus mediating nonopioid stress-induced analgesia in female mice. J. Neurosci. 17:1997;7995-8002.
50. Mogil J.S., Wilson S.G., Bon K., Lee S.E., Chung K., Raber P.J., Pieper O.P., Hain H.S., Belknap J.K., Hubert L., Elmer G.I., Chung J.M., Devor M. Heritability of nociception I: responses of 11 inbred mouse strains on 12 measures of nociception. Pain. 80:1999;67-82.
51. Moreau J.-L., Fields H.L. Evidence for GABA involvement in midbrain control of medullary neurons that modulate nociceptive transmission. Brain Res. 397:1986;37-46.
52. Murray T.F., McGill W., Cheney D.L. A comparison of the analgesic activities of 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol (THIP) and 6-chloro-2[1-piperazinyl]pyrazine (MK 212). Eur. J. Pharmac. 90:1983;179-184.
53. A receptors and spinally mediated antinociception in rats. J. Pharmac. exp. Ther. 278:1996;620-626.
54. Oliverio A., Castellano C., Eleftheriou B.E. Morphine sensitivity and tolerance: a genetic investigation in the mouse. Psychopharmacologia. 42:1975;219-224.
55. Onaka M., Minami T., Nishihara I., Ito S. Involvement of glutamate receptors in strychnine- and bicuculline-induced allodynia in conscious mice. Anesthesiology. 84:1996;1215-1222.
56. A receptor subunit mRNAs in neurons of the rat spinal cord and dorsal root ganglia. Neuroscience. 42:1991;497-507.
57. A receptor subunits in the rat CNS. J. comp. Neurol. 326:1992;193-216.
58. Pick C.G., Cheng J., Paul D., Pasternak G.W. Genetic influences in opioid analgesic sensitivity in mice. Brain Res. 566:1991;295-298.
59. Quinlan J.J., Homanics G.E., Firestone L.L. Anesthesia sensitivity in mice that lack the β3 subunit of the γ-aminobutyric acid type A receptor. Anesthesiology. 88:1998;775-780.
60. Rady J.J., Fujimoto J.M. Spinal GABA receptors mediate brain delta opioid analgesia in Swiss Webster mice. Pharmac. Biochem. Behav. 51:1995;655-659.
61. 1-receptor agonist, morphine, and an NMDA-receptor antagonist. J. Neurophysiol. 79:1998;1494-1507.
62. Roberts L.A., Beyer C., Komisaruk B.R. Nociceptive responses to altered GABAergic activity at the spinal cord. Life Sci. 39:1986;1667-1674.
63. A receptors in the midbrain periaqueductal gray abolishes nociceptive spinal dorsal horn neuronal activity. Eur. J. Pharmac. 160:1989;163-166.
64. Sawynok J., Dickson C. Evidence for the involvement of descending noradrenergic pathways in the antinociceptive effect of baclofen. Brain Res. 335:1985;89-97.
65. Sawynok J., LaBella F.S. On the involvement of GABA in the analgesia produced by baclofen, muscimol and morphine. Neuropharmacology. 21:1982;397-403.
66. A receptors. Trends pharmac. Sci. 18:1997;425-429.
67. A and glycine receptors to central sensitization: disinhibition and touch-evoked allodynia in the spinal cord. J. Neurophysiol. 72:1994;169-179.
68. 3H]muscimol binding sites in rat dorsal spinal cord after neonatal capsaicin treatment. Brain Res. 202:1980;484-487.
69. A receptors. Trends pharmac. Sci. 16:1995;162-168.
70. A receptors. Biochem. J. 310:1995;1-9.
71. B receptors in presynaptic inhibition of Ia EPSPs in cat spinal motoneurones. J. Physiol., Lond. 447:1992;675-692.
72. Suh H.-W., Kim Y.-H., Choi Y.-S., Choi S.-R., Song D.-K. Effects of GABA receptor antagonists injected spinally on antinociception induced by opioids administered supraspinally in mice. Eur. J. Pharmac. 307:1996;141-147.
73. A receptor γ2 subunit in the rat spinal cord. Eur. J. Neurosci. 7:1995;1323-1332.
74. Thomas D.A., Naverrete I.M., Graham B.A., McGowan M.K., Hammond D.L. Antinociception produced by systemic R(+)-baclofen hydrochloride is attenuated by CGP 35348 administered to the spinal cord or ventromedial medulla of rats. Brain Res. 718:1996;129-137.
75. Todd A.J., Watt C., Spike R.C., Sieghart W. Colocalization of GABA, glycine, and their receptors at synapses in the rat spinal cord. J. Neurosci. 16:1996;974-982.
76. A receptor antagonist, produce potent analgesia as measured in the tail pinch test in mice. Eur. J. Pharmac. 136:1987;129-131.
77. A receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J. Neurosci. 12:1992;1040-1062.
78. Yaksh T.L. Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists. Pain. 37:1989;111-123.
79. Yaksh T.L., Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol. Behav. 17:1976;1031-1036.
80. Yang S.-W., Guo Y.-Q., Kang Y.-M., Qiao J.-T., Laufman L.E., Dafny N. Different GABA-receptor types are involved in the 5-HT-induced antinociception at the spinal level: a behavioral study. Life Sci. 62:1998;143-148.
81. A receptor β subunit heterogeneity: functional expression of cloned cDNAs. Eur. molec. Biol. Org. J. 8:1989;1665-1670.
82. Zar J. H. (1974) Biostatistical Analysis, p. 696. Prentice-Hall, Inc., Englewood Cliffs.
83. A receptor in the rat brain. J. comp. Neurol. 303:1991;637-657.